ArticleMolecular oncology2014

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.

Anieta M Sieuwerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.